By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Markets Open Lower On Weak Meta Earnings
U.S. markets opened lower as disappointing Meta earnings dragged down the tech-heavy Nasdaq. Today, investors will be watching for Amazon's Q4 earnings report set for release after the market close. Greg Swenson, Founding Partner, Brigg Macadam joined Cheddar's Opening Bell to discuss.
Stocks Open Mostly Higher on Strong Tech Earnings
Markets opened mostly higher led by gains in the tech sector on strong Q4 earnings. It comes after a tumultuous January which saw stocks suffer one of their worst months since the early days of the pandemic. Jim Worden, Chief Investment Officer, Wealth Consulting Group joined Cheddar's Opening Bell to discuss early market activity.
Organon to Give Employees A Paid Day Off on International Women's Day
Women's health company Organon will give its over 9,000 employees a paid day off on International Women's Day. The move comes as the company aims to recognize the growing health inequities women have faced during the Covid-19 pandemic. Kevin Ali, Chief Executive Officer, Organon joined Cheddar's Opening Bell to discuss.
Fitness Brand CLMBR Shaking Up The At-Home Fitness Industry
CLMBR is hoping to become the next big thing in connected fitness. The brand offers a high intensity, low impact workout with on-demand, instructor-led classes. Avrum Elmakis, CLMBR's CEO and founder, joined Cheddar to discuss where the company is heading next.
Amazon, Nike Considering Potential Bids For Peloton
Peloton is reportedly drawing interest from multiple suitors. According to the Wall Street Journal, Amazon is considering acquiring the exercise bike company as it looks to expand into the health and wellness technology industry. Hatem Dhiab, managing partner at Gerber Kawasaki, joined Cheddar to discuss Peloton's future and which company might be its best bet as a buyer.
Amazon Shares Jump on Solid Cloud Revenue, Profit From Rivian Stake
Amazon shares jumped north of 13 percent in after-hours trading as the E-commerce giant posted a beat on earnings in its fourth quarter. Amazon saw particular success in its cloud computing business, as well as its stake in EV startup, Rivian after its massive IPO. Deren Baker, CEO, Edge by Ascential joined Cheddar's Opening Bell to discuss.
Load More